Assessment of the Neuropeptide S System in Anxiety Disorders
暂无分享,去创建一个
J. Suvisaari | L. Peltonen | M. Gratacós | X. Estivill | J. Kere | J. Terwilliger | J. Lönnqvist | M. Wickman | K. Silander | G. Pershagen | S. Pirkola | M. D’Amato | C. Söderhäll | I. Hovatta | M. Zucchelli | M. Torrens | H. Alenius | R. Martin-Santos | R. Haapakoski | E. Mélen | L. Johansson | S. Ezer | C. Orsmark-Pietras | J. Donner | Francesca Anedda | R. Martín-Santos | Christina Orsmark-Pietras
[1] M. Dierssen,et al. Susceptibility to stress in transgenic mice overexpressing TrkC, a model of panic disorder. , 2010, Journal of psychiatric research.
[2] R. Reinscheid,et al. Behavioral phenotyping of Neuropeptide S receptor knockout mice , 2009, Behavioural Brain Research.
[3] J. Koo,et al. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory , 2009, Neuroscience Letters.
[4] V. Lefebvre,et al. SOX5 postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-layer neocortical neurons , 2008, Proceedings of the National Academy of Sciences.
[5] M. Wickman,et al. Phenotypes of food hypersensitivity and development of allergic diseases during the first 8 years of life , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[6] R. Stewart,et al. The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats. , 2008, Alcoholism, clinical and experimental research.
[7] H. Pape,et al. Neuropeptide S-Mediated Control of Fear Expression and Extinction: Role of Intercalated GABAergic Neurons in the Amygdala , 2008, Neuron.
[8] Y. Yanagawa,et al. Identification of a Neuropeptide S Responsive Circuitry Shaping Amygdala Activity via the Endopiriform Nucleus , 2008, PloS one.
[9] L. Peltonen,et al. An Association Analysis of Murine Anxiety Genes in Humans Implicates Novel Candidate Genes for Anxiety Disorders , 2008, Biological Psychiatry.
[10] Wayne Katon,et al. Anxiety disorders and comorbid medical illness. , 2008, General hospital psychiatry.
[11] S. Salvadori,et al. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice , 2008, British journal of pharmacology.
[12] Frank Dudbridge,et al. Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype Data , 2008, Human Heredity.
[13] J. Celedón,et al. Comprehensive testing of positionally cloned asthma genes in two populations. , 2007, American journal of respiratory and critical care medicine.
[14] C. Diéguez,et al. Nicotine treatment regulates neuropeptide S system expression in the rat brain. , 2007, Neurotoxicology.
[15] W. Katon,et al. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[16] K. Hashimoto,et al. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] G. O'Connor,et al. Genome-wide association of sleep and circadian phenotypes , 2007, BMC Medical Genetics.
[18] A. Sourander,et al. Who is at greatest risk of adverse long-term outcomes? The Finnish From a Boy to a Man study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[19] C. Lindgren,et al. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. , 2007, Gastroenterology.
[20] M. Nei,et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.
[21] Benjamin W. H. Lim,et al. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars , 2007, Proceedings of the National Academy of Sciences.
[22] W. Katon,et al. Impact of anxiety and depression on functional impairment in adolescents with asthma. , 2007, General hospital psychiatry.
[23] Eden R Martin,et al. No gene is an island: the flip-flop phenomenon. , 2007, American journal of human genetics.
[24] C. Diéguez,et al. Caffeine treatment regulates neuropeptide S system expression in the rat brain , 2006, Neuroscience Letters.
[25] M. Gratacós,et al. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction , 2006, Neurobiology of Disease.
[26] J. Kere,et al. Downstream target genes of the neuropeptide S-NPSR1 pathway. , 2006, Human molecular genetics.
[27] Wayne Katon,et al. Asthma Symptom Burden: Relationship to Asthma Severity and Anxiety and Depression Symptoms , 2006, Pediatrics.
[28] Dan J Stein,et al. Early maternal separation followed by later stressors leads to dysregulation of the HPA-axis and increases in hippocampal NGF and NT-3 levels in a rat model , 2006, Metabolic Brain Disease.
[29] S. Bloom,et al. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. , 2006, Endocrinology.
[30] Shinjae Chung,et al. Pharmacological Characterization of Human and Murine Neuropeptide S Receptor Variants , 2005, Journal of Pharmacology and Experimental Therapeutics.
[31] J. Lönnqvist,et al. Childhood adversities as risk factors for adult mental disorders , 2005, Social Psychiatry and Psychiatric Epidemiology.
[32] C. Lemière,et al. Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients? , 2005, Respiratory medicine.
[33] S. Weiland,et al. G-Protein-coupled receptor polymorphisms are associated with asthma in a large German population. , 2005, American journal of respiratory and critical care medicine.
[34] D. Kleinbaum,et al. Asthma and panic in young adults: a 20-year prospective community study. , 2005, American journal of respiratory and critical care medicine.
[35] C. Lindgren,et al. Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma. , 2005, American journal of respiratory and critical care medicine.
[36] J. Kere,et al. Positionally cloned susceptibility genes in allergy and asthma. , 2004, Current opinion in immunology.
[37] D. Fergusson,et al. Asthma and depressive and anxiety disorders among young persons in the community , 2004, Psychological Medicine.
[38] S. Henriksen,et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. , 2004, Neuron.
[39] Paula Lozano,et al. The Relationship of Asthma and Anxiety Disorders , 2004, Psychosomatic medicine.
[40] Thomas J. Hudson,et al. Characterization of a Common Susceptibility Locus for Asthma-Related Traits , 2004, Science.
[41] F. Jacobi,et al. Mental disorders and asthma in the community. , 2003, Archives of general psychiatry.
[42] M. Wickman,et al. The BAMSE Project: presentation of a prospective longitudinal birth cohort study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[43] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[44] J M Gorman,et al. Neuroanatomical hypothesis of panic disorder, revised. , 2000, The American journal of psychiatry.
[45] P. Sacerdote,et al. Plasma interleukin-1 beta concentrations in panic disorder , 1994, Psychiatry Research.
[46] W. Schaffner,et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.
[47] C. Gall,et al. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S‐expressing neurons in the rat brain , 2007, The Journal of comparative neurology.
[48] J. Suvisaari,et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population , 2005, Social Psychiatry and Psychiatric Epidemiology.
[49] R. Goodwin. Asthma and anxiety disorders. , 2003, Advances in psychosomatic medicine.
[50] W. Katon,et al. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature. , 1996, Bulletin of the Menninger Clinic.
[51] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .